This was shown in a murine model (LNCaP tumour xenografts expressing PSMA) to have an extended blood retention time, with delivery of an 8.3-fold higher absorbed radiation dose compared to 177Lu-PSMA-617. Here, FOLH1 is linked to neoplasm.